4.6 Review

Atg8-Family Proteins-Structural Features and Molecular Interactions in Autophagy and Beyond

期刊

CELLS
卷 9, 期 9, 页码 -

出版社

MDPI
DOI: 10.3390/cells9092008

关键词

Atg8; LC3; GABARAP; LIR motif; SAR; UBL; autophagy

资金

  1. Innovative Medicines Initiative 2 Joint Undertaking (JU) [SFB 1177]
  2. European Union [875510]
  3. EFPIA
  4. Ontario Institute for Cancer Research
  5. Royal Institution for the Advancement of Learning McGill University
  6. Diamond Light Source Limited [1097737]
  7. AbbVie
  8. Bayer Pharma AG
  9. Canada Foundation for Innovation, Eshelman Institute for Innovation
  10. Merck KGaA, Darmstadt, Germany
  11. Ontario Ministry of Research, Innovation and Science (MRIS)
  12. Pfizer, Sao Paulo Research Foundation-FAPESP
  13. Takeda [106169/ZZ14/Z]
  14. CRUK program
  15. Marie Sklodowska-Curie ETN [C2739/A22897]
  16. [765912]

向作者/读者索取更多资源

Autophagy is a common name for a number of catabolic processes, which keep the cellular homeostasis by removing damaged and dysfunctional intracellular components. Impairment or misbalance of autophagy can lead to various diseases, such as neurodegeneration, infection diseases, and cancer. A central axis of autophagy is formed along the interactions of autophagy modifiers (Atg8-family proteins) with a variety of their cellular counter partners. Besides autophagy, Atg8-proteins participate in many other pathways, among which membrane trafficking and neuronal signaling are the most known. Despite the fact that autophagy modifiers are well-studied, as the small globular proteins show similarity to ubiquitin on a structural level, the mechanism of their interactions are still not completely understood. A thorough analysis and classification of all known mechanisms of Atg8-protein interactions could shed light on their functioning and connect the pathways involving Atg8-proteins. In this review, we present our views of the key features of the Atg8-proteins and describe the basic principles of their recognition and binding by interaction partners. We discuss affinity and selectivity of their interactions as well as provide perspectives for discovery of new Atg8-interacting proteins and therapeutic approaches to tackle major human diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据